Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Novartis and NHS launch mobile eye unit in UK

First of its kind unit to offer 250 clinic slots per week across Surrey, Hampshire and Berkshire

- PMLiVE

AbbVie takes PARP inhibitor into third phase III trial

Veliparib under investigation for use in advanced breast cancer

- PMLiVE

Avastin first biologic backed in EU for resistant ovarian cancer

Roche drug recommended in latest round of CHMP opinions

- PMLiVE

Care.Data pilot to be limited to just 100 GP practices

HSCIC admits 'pain' of last 12 months but says health data has transformational potential

- PMLiVE

Astellas picks PhRMA’s Uhlendorf for US public affairs lead

He will leave his role as VP, communications and public affairs at US trade body

- PMLiVE

Langland triumphs at IPA Best of Health Awards

Windsor, UK agency wins Best of Show for Idis campaign

Conversis Medical names Mark Hooper global director

He brings 13 years' experience in pharma services to the role

Bristol-Myers Squibb (BMS) building

BMS to publish full clinical study reports in transparency drive

Partners with Duke University to grant access back to 2008

- PMLiVE

AZ needs more data on olaparib, says FDA panel

Agency advisers demands more safety information on ovarian cancer drug

- PMLiVE

NICE backs Janssen’s once-daily diabetes drug

Invokana is the tenth treatment recommended in England and Wales to lower blood sugar levels

- PMLiVE

IMS Health pays €385m for Cegedim businesses

Market research firm takes over information solutions and CRM services

- PMLiVE

Packer Forbes and emotive agree collaborative tie-up

Will work together on project-by-project basis to offer integrated comms support

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links